Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Breast 7Gastrointestinal 4Genitourinary 3Thoracic 2Gynecologic 2Tumor-Agnostic 1Sarcoma 1Other solid neoplasm 1Other 1Lymphoid 1Endocrine 1

Conditions

Lung Neoplasms 2Pleural Effusion 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Biomarkers × Thoracic × Clear all
NCT07012759 2026-03-05

Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients

Fu Jen Catholic University

Recruiting
100 enrolled
Thoracic

Adenocarcinoma of Lung, Lung Neoplasms, Pleural Effusion

NCT03286036 2019-02-15

Clinical and Molecular Staging of Lung Cancer Stages I and IIp

Corporacion Parc Tauli

Unknown
200 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡